Fig. 3From: Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis ChemovarsEstimated number of side effects for distinct chemovars. Note: The estimated means are adjusted for baseline symptom severity level, total volume of terpenes in each product, and total number of recorded side effects (bars indicate 95% confidence intervals).Back to article page